申请人:Lapierre Jean-Marc
公开号:US20070281955A1
公开(公告)日:2007-12-06
The present invention provides imidazooxazole and imidazothiazole compounds and their synthesis. The compounds of the present invention are capable of inhibiting the activity of RAF kinase, such as B-RAF
V600E
. The compounds are useful for the treatment of cell proliferative disorders such as cancer.
本发明提供了咪唑氧唑和咪唑硫唑化合物及其合成方法。本发明的化合物能够抑制RAF激酶的活性,例如B-RAFV600E。这些化合物对于治疗细胞增殖性疾病,如癌症,具有有用的作用。